Tocilizumab and Corticosteroids Increase Risk of COVID-19–Associated Pulmonary Aspergillosis Development Among Critically Ill Patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tocilizumab and Corticosteroids Increase Risk of COVID-19–Associated Pulmonary Aspergillosis Development Among Critically Ill Patients

Published:2023-03-08 Issue:3 Volume:30 Page:e268-e274
ISSN:1075-2765
Container-title:American Journal of Therapeutics
language:en
Short-container-title:

Author:

Awad Mohammed T.¹,Niwinski Rajmund Michal²,Beran Azizullah³,Tidwell Chad⁴,Soubani Ayman O.¹

Affiliation:

1. Division of Pulmonary, Critical Care and Sleep Medicine, Wayne State University School of Medicine, Detroit, MI

2. Wayne State University School of Medicine, Detroit, MI

3. Division of Gastroenterology and Hepatology, Indiana University, Indianapolis, IN

4. Internal Medicine Department, Wayne State University School of Medicine, Detroit, MI

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology,General Medicine

Reference33 articles.

1. COVID-19-associated coagulopathy and disseminated intravascular coagulation;Asakura;Int J Hematol,2021

2. Invasive pulmonary aspergillosis among intubated patients with SARS-CoV-2 or influenza pneumonia: a European multicenter comparative cohort study;Rouzé;Crit Care,2022

3. Invasive pulmonary aspergillosis in critically ill patients with hematological malignancies;Pardo;Intensive Care Med,2019

4. Coronavirus disease 2019–associated pulmonary aspergillosis: do we have the CAPAcity to improve outcomes?;Baddley;Clin Infect Dis,2022

5. COVID-19-Associated pulmonary aspergillosis (CAPA);Dimopoulos;J Intensive Med,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors affecting mortality in COVID-19-associated pulmonary aspergillosis: An international ID-IRI study;Heliyon;2024-07

2. Lung infections due to emerging fungal pathogens;Current Opinion in Pulmonary Medicine;2024-02-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3